ORAL-CONTRACEPTIVES AND CORONARY HEART-DISEASE - MODULATION OF GLUCOSE-TOLERANCE AND PLASMA-LIPID RISK-FACTORS BY PROGESTINS

被引:48
作者
CROOK, D
GODSLAND, IF
WYNN, V
机构
关键词
D O I
10.1016/0002-9378(88)90199-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:1612 / 1620
页数:9
相关论文
共 86 条
[1]  
Adams P W, 1980, J Pharmacother, V3, P54
[2]  
ALBERS JJ, 1984, CLIN METABOLIC ASPEC, P381
[3]  
ASSMANN G, 1982, LIPID METABOLISM ATH, P155
[4]  
BACHORIK PS, 1985, CLIN CHEM, V31, P1107
[5]   HIGH-DENSITY AND LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION AND IN CONTROL SUBJECTS [J].
BALLANTYNE, FC ;
CLARK, RS ;
SIMPSON, HS ;
BALLANTYNE, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :433-437
[6]  
BARR DP, 1951, AM J MED, V11, P480, DOI 10.1016/0002-9343(51)90183-0
[7]  
BATZER FR, 1986, J REPROD MED, V31, P848
[8]  
BAYLISS R, 1987, J ROY COLL PHYS LOND, V21, P134
[9]   CONTRACEPTIVE STEROIDS - MODIFICATIONS OF CARBOHYDRATE AND LIPID-METABOLISM [J].
BECK, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1973, 22 (06) :841-855
[10]   ASSESSMENT OF INSULIN SENSITIVITY INVIVO [J].
BERGMAN, RN ;
FINEGOOD, DT ;
ADER, M .
ENDOCRINE REVIEWS, 1985, 6 (01) :45-86